The effects of acupuncture on cardiac muscle cells and blood pressure in spontaneous hypertensive rats

If acupuncture is able to prevent hypertrophy of the heart, it could therefore prevent the heart from overloading and thus prevent heart failure or sudden death. We therefore studied the effects of acupuncture on blood pressure and cardiac muscle cells. Rats with spontaneous hypertension were divided into three acupuncture treatment groups and one non-treatment group. The treatment groups were classified as sham acupoint, Yanglingquan (GB. 34) and Quchi (LI. 11) groups. The measurements recorded included changes in tail pressure, femoral arterial pressure, left ventricular weight (LVW), whole heart weight (WHW), body weight (BW), LVW/BW and WHW/BW ratios and the size of the cardiac muscle cells. The results showed that femoral arterial pressure of subjects which were needled on the selected points for 3 days dropped. Acupuncture at these two acupoints seemed to improve the condition of hypertension in a short period of time. Significant changes in the femoral arterial pressure were observed in all subjects when they were treated for 6 days. In the two acupoint groups, the LVW/BW and the WHW/BW ratios did not change significantly. Cardiac muscle cells reduced in size in the Yanglingquan (GB. 34) treatment groups. This indicates that the Yanglingquan (GB. 34) points not only can lower blood pressure, but also prevent hypertrophy of cardiac muscle cells in spontaneous hypertensive rats (SHR). Therefore, acupuncture could be a good treatment modality for hypertension and hypertrophy of the heart.     

解郁丸对高血压伴焦虑患者的血压和生活质量的影响

目的：探讨解郁丸对高血压伴焦虑患者血压和生活质量的影响.方法：对122例高血压患者进行焦虑自评量表（SAS）评分,将评分阳性者随机分为治疗组（苯磺酸氨氯地平片＋解郁丸）及对照组（苯磺酸氨氯地平片）,评分阴性者为无焦虑组（苯磺酸氨氯地平片）.观察治疗6周后三组患者降压效果及生活质量评分.结果：治疗组、无焦虑组较对照组降压效果明显提高,治疗组SAS评分显著低于对照组,生活质量评分显著高于对照组.结论：解郁丸治疗高血压伴焦虑患者能明显提高降压疗效,显著降低高血压患者焦虑的严重程度,提高生活质量.     

Effect of aqueous extract of Adenia cissampeloides on blood pressure and serum analytes of hypertensive patients

Seven female hypertensive subjects, being treated with an aqueous extract of Adenia cissampeloides, (‘Adenia’), and seven weight-, age- and sex-matched hypertensive subjects about to begin treatment, were used to evaluate the therapeutic and possible toxic effects of this herbal preparation which is used at the Centre for Scientific Research into Plant Medicine (CSRPM), to control hypertension. Measurements of systolic and diastolic blood pressures were recorded, and serum levels of α-hydroxybutyrate dehydrogenase (HBDH), aspartate aminotransferase (AST), lactate dehydrogenase (LDH) and creatine kinase (CK) were determined to give an indication of the effectiveness of ‘Adenia’ as an anti-hypertensive agent. Serum levels of γ-glutamyl transferase (GGT), alanine aminotransferase (ALT), alkaline phosphatase (ALP), bilirubin, proteins and cholesterol were used to indicate possible liver damage, and blood urea nitrogen (BUN), serum creatinine and creatinine clearance rate were determined for the assessment of possible nephrotoxicity. Systolic blood pressure was significantly lower in subjects on ‘Adenia’ compared to the control subjects not on ‘Adenia’. (p <0.01). HBDH and CK, were lower in the patients on ‘Adenia’, but the differences were not statistically significant. Levels of total and conjugated bilirubin were significantly lower in the subjects on ‘Adenia’, (P < 0.05). The plant preparation appears not to have hepatotoxic or nephrotoxic effects.     

潜阳合剂加载对老年高血压病患者脉压差及血压晨峰的影响

目的观察常规西药基础上加载潜阳合剂(地黄、钩藤、牡蛎等)治疗对老年高血压病患者脉压差及高血压晨峰的影响。方法将112例患者随机分为治疗组和对照组,对照组用常规抗高血压西药(苯磺酸氨氯地平片,厄贝沙坦片,氢氯噻嗪片),治疗组另加载潜阳合剂。观察治疗前后患者诊室血压、动态血压、症候积分的变化及症候疗效。结果治疗后,治疗组诊室收缩压(SBP)、脉压差(PP)明显低于对照组(P0.01);治疗组动态血压监测清晨SBP、晨峰程度均明显低于对照组(P0.01);治疗组中医症候明显改善,总症候积分较对照组有统计学意义(P0.01);治疗组中医症候总有效率83.93%,显著优于对照组(P0.01)。结论在西药基础上加载中药潜阳合剂不仅能有效改善老年高血压患者阴虚阳亢症状,且能有效减小其晨峰幅度和脉压差。     

杞菊地黄汤对老年高血压患者血压变异的影响

目的:观察杞菊地黄汤对老年高血压患者血压变异性以及血浆血管紧张素Ⅱ(AngⅡ)和高敏C反应蛋白(hsCRP)水平的影响。方法:56例原发性高血压老年患者,随机分为对照组和治疗组,对照组给予苯磺酸左旋氨氯地平片5mg/d,治疗组给予苯磺酸左旋氨氯地平片5mg/d加服杞菊地黄汤,连续治疗4周。动态血压监测法记录24h、日间、夜间收缩压、舒张压平均值及标准差(STD)。自动生化分析仪检测血脂水平,酶标多克隆抗体夹心法检测AngⅡ和hs-CRP浓度。结果:两组患者药物治疗后,血压值与治疗前比较均有不同程度的降低,而治疗组的24h收缩压(24hSBP)和日间收缩压(dSBP)在药物治疗后较对照组显著降低(P0.05)。对照组在治疗前后的血压变异值未见显著变化;而治疗组患者的24hSBPSTD和dSBPSTD,在治疗前后均有显著性差异(P0.05),两组治疗后的24hSBPSTD和dSBPSTD也存在显著差异(P0.05)。此外,对照组在治疗前后的AngⅡ、hsCRP和血脂水平未见显著变化;而治疗组患者的AngⅡ、hsCRP、TG和LDL-C水平,均较治疗前显著降低(P0.05)。结论:杞菊地黄汤可以显著降低老年高血压患者24h收缩压变异性和日间收缩压变异性,并改善血浆AngⅡ、hsCRP和血脂水平。     

Effect of Eucommia ulmoides on systolic blood pressure in the spontaneous hypertensive rat

Experiments were conducted to establish the safety and efficacy of Eucommia ulmoides (Du-Zhong) extract in the treatment of hypertension. Pilot experiments using rats demonstrated that E. ulmoides extract was safe to the saturation limits of the compound. The maximum tolerated dose (MTD) was 1200 mg/kg when administered by gastric gavage at a concentration of 1200 mg/ml. Also, rats given 200 mg/kg, 600 mg/kg or 1200 mg/kg doses of E. ulmoides extract daily for 28 days demonstrated no evidence of acute toxicity as determined by clinical appearance, histopathology and serum chemistry evaluation. Lastly, spontaneous hypertensive rats (SHRs) were administered E. ulmoides extract daily for 22 days. Systolic blood pressure (BP) was measured on treatment days 1, 8, 15 and 22 at 0, 1, 2 and 3 hours post-treatment. Beginning on day 8, E. ulmoides extract administered at the mid or high dosages lowered BP in male, but not female, rats. BP declined at a rate of approximately 10 mmHg per hour. The mid dosage of 600 mg/kg was found to be the minimum effective dose. In conclusion, E. ulmoides extract was non-toxic and effective in reducing systolic BP in the SHR.     

郁病患者血液流变学变化及针刺对其干预作用

郁病的主要病理机制为厌恶憎恨、愤懑恼怒等精神因素，扰乱元神，神不导气，使肝失调达，气机不畅，以致肝气郁结而成气郁。肝郁与血瘀是郁病中两个紧密相关的病理过程。肝具有疏泄和藏血两大生理功能。肝藏血之功，在于调节血脉之用，他与肝的疏泄正常与否密切相关。若疏泄异常，则血溢脉外，或血行缓慢，停滞而为瘀血。此中医理论的临床客观性已被许多研究所证实。     

Effects of wet-cupping on blood pressure in hypertensive patients:a randomized controlled trial

BACKGROUND: Although cupping remains a popular treatment modality worldwide, its effi cacy for most diseases, including hypertension, has not been scientifi cally evaluated.OBJECTIVE: We aimed to determine the effi cacy of wet-cupping for high blood pressure, and the incidence of the procedure's side effects in the intervention group. DESIGN, SETTING, PARTICIPANTS AND INTERVENTIONS: This is a randomized controlled trial conducted in the General Practice Department at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, between May 2013 and February 2014. There were two groups(40 participants each): intervention group undergoing wet-cupping(hijama) in addition to conventional hypertension treatment, and a control group undergoing only conventional hypertension treatment. Three wet-cupping sessions were performed every other day. MAIN OUTCOME MEASURE: The mean systolic and diastolic blood pressures were measured using a validated automatic sphygmomanometer. The follow-up period was 8 weeks. RESULTS: Wet-cupping provided an immediate reduction of systolic blood pressure. After 4 weeks of follow-up, the mean systolic blood pressure in the intervention group was 8.4 mm Hg less than in the control group(P = 0.046). After 8 weeks, there were no signif icant differences in blood pressures between the intervention and control groups. In this study, wet-cupping did not result in any serious side effects. CONCLUSION: Wet-cupping therapy is effective for reducing systolic blood pressure in hypertensive patients for up to 4 weeks, without serious side effects. Wet-cupping should be considered as a complementary hypertension treatment, and further studies are needed.     

针箭颗粒对自发性高血压大鼠血压及胰岛素抵抗的影响

目的 :观察针箭颗粒对自发性高血压大鼠 (SHR)血压和胰岛素抵抗 (Insulinresistance ,IR)的影响。方法 :取 13周龄SHR大鼠 2 4只随机分为针箭颗粒大、小剂量治疗组及模型对照组 3组 ,另取WKY大鼠 6只为正常对照组 ,治疗 8周后进行血压、空腹血糖 (G)、胰岛素 (I ,放免法测定 )、G/I、血脂的前后及组间比较。结果 :治疗前各组SHR大鼠空腹G虽与WKY大鼠无显著差异 ,但空腹I明显高于、G/I明显低于WKY大鼠 (P <0 .0 1) ,治疗后两治疗组空腹I、CHO、TG较模型组和 /或治疗前均有不同程度下降 ,G/I、HDL C较模型组则明显升高 (P <0 .0 1～ 0 .0 5 ) ,大剂量组空腹G较治疗前也有明显下降 (P <0 .0 5 )。结论 :针箭颗粒降低SHR大鼠血压的同时能够显著改善其伴随的IR。     

辨证取穴针刺对原发性高血压病患者血压及甲襞微循环的影响

目的:验证辨证取穴针刺治疗原发性高血压病的疗效,探讨针刺治疗原发性高血压痛的机制.方法:将135例原发性高血压病患者随机分为观察组(108例)和对照组(27例).两组均予常规针刺风池、曲池、足三里、三阴交,观察组在此基础上予中医辩证配穴,对照组不取配穴,每日1次.针刺15天后观察患者疗效和甲襞微循环的变化.结果:观察组...     

调督熄风针法对肝阳上亢非杓型高血压病患者血压昼夜节律、血压变异性、平滑指数的影响

目的探讨调督熄风针法对肝阳上亢非杓型高血压病患者血压昼夜节律、血压变异性、平滑指数的影响。方法将符合入组标准的69例肝阳上亢非杓型高血压病患者随机分为2组,对照组34例口服马来酸左旋氨氯地平,治疗组35例口服马来酸左旋氨氯地平基础上于申时行调督熄风针法,2组均治疗4周,比较2组患者治疗前后动态血压[24 h平均收缩压(24hMSBP)、24 h平均舒张压(24hMDBP)、白天平均收缩压(dMSBP)、白天平均舒张压(dMDBP)、夜间平均收缩压(nMSBP)、夜间平均舒张压(nMDBP)]、血压昼夜节律、血压变异性[24 h平均收缩压变异性(24hSBPV)、24 h平均舒张压变异性(2 4hDBPV)、白天收缩压变异性(dSBPV)、白天舒张压变异性(dDBPV)、夜间收缩压变异性(nSBPV)、夜间舒张压变异性(nDBPV)]、平滑指数[24 h平均收缩压平滑指数(24hSBPSI)、24 h平均舒张压平滑指数(24hDBPSI)、白天收缩压平滑指数(dSBPSI)、白天舒张压平滑指数(dDBPSI)、夜间收缩压平滑指数(nSBPSI)、夜间舒张压平滑指数(nDBPSI)]。结果 2组治疗后的动态血压、血压变异性各指标均明显低于治疗前(P均0.05),且治疗组的nMSBP、nMDBP、nSBPV、nDBPV均明显低于对照组(P均0.05);2组治疗后的平滑指数以及血压昼夜节律、转变杓型人数均明显高于治疗前(P均0.05),且治疗组的nSBPSI、nDBPSI及血压昼夜节律、转变杓型血压人数均明显高于对照组(P均0.05)。结论申时行调督熄风针法能对肝阳上亢非杓型高血压病患者起到减小血压波动、降低全天血压水平、改善昼夜节律、平稳降压的作用,尤其是在改善夜间血压方面更有优势。     

“调神潜阳”针刺法对伴有高血压的卒中相关睡眠障碍患者血压及睡眠质量的影响

目的:观察"调神潜阳"针刺法对伴有高血压的卒中相关睡眠障碍(SSD)患者清晨血压、睡眠质量以及脑卒中神经功能恢复的影响。方法:将120例患者随机分为观察组(60例)和对照组(60例,脱落1例),两组均施以醒脑开窍针刺法(内关、水沟、三阴交、极泉、尺泽、委中),观察组加用"调神潜阳"针刺法,针刺百会、四神聪深纳久留针5 h。每日针刺1次,每周5次,共治疗30次。检测两组患者治疗期间清晨血压;观察两组治疗前后匹兹堡睡眠质量指数(PSQI)、美国国立卫生研究院卒中量表(NIHSS)评分。结果:两组治疗后清晨收缩压(SBP)均较治疗前降低(P<0.05),观察组治疗后清晨舒张压(DBP)较治疗前降低(P<0.05),且观察组清晨SBP、DBP低于对照组(P<0.05)。观察组治疗后PQSI总分、NIHSS评分均较治疗前降低(P<0.01,P<0.05),且观察组PQSI总分、NIHSS评分低于对照组(P<0.01,P<0.05),NIHSS减分率高于对照组(P<0.05)。结论:在醒脑开窍针刺法基础上,加用"调神潜阳"针刺法可明显改善伴有高血压的...     

老年高血压的动态血压监测

目的：探讨老年高血压病患者24h动态血压波动规律及范围。方法选择我院近2年收治的65例老年高血压患者进行24h动态血压监测。结果老年高血压病患者的血压均值收缩压（sBP）和舒张压（DBP）各时间点上的平均SBP与DBP均高于正常老年人组。结论：通过对老年高血压患者在治疗中定期进行动态血压监测,及时发现具有潜在危险的老年高血压病患者,对指导临床治疗和判断预后有着十分重要的意义。     

舒脑欣滴丸对自发性高血压大鼠降压及心肌保护作用研究

目的观察舒脑欣滴丸对自发性高血压(SHR)大鼠的降压及心肌保护作用。方法将SHR大鼠按血压和体质量随机分为模型组、舒脑欣滴丸(800 mg/kg)组和阳性药缬沙坦(1 mg/kg)组。以同龄同种系正常血压的京都种(WKY)大鼠作为对照组,各组ig给药,采用无创血压计测定其血压,给药6周后测定大鼠血清中一氧化氮合酶(NOS)和血管紧张素Ⅱ(AngⅡ)的水平,并利用多普勒超声心动检查方法测定左心室质量,利用HE染色观察主动脉和心肌组织形态变化。结果舒脑欣滴丸(800mg/kg)单次给药后,SHR大鼠血压在1h后降到最低,长期给药6周后,可以稳定SHR大鼠的血压;舒脑欣滴丸治疗6周后,大鼠血清中NOS水平显著高于模型组(P0.05),AngⅡ水平显著低于模型组(P0.05),舒脑欣滴丸给药组的左心室质量显著低于模型组(P0.05),且舒脑欣滴丸可改善高血压引起的胸主动脉血管和心肌形态异常。结论舒脑欣滴丸对高血压伴有心肌肥厚大鼠具有一定治疗作用,可作为高血压伴心肌肥厚病症的潜在药物进行研究。     

磁极针对高血压病患者血压及血浆内皮素的影响

目的：探讨磁极针对高血压病患血压及血浆内皮素（ET）含量的影响。方法：60例高血压病患者随机分为磁极针组和对照组各30例，二组均予基础治疗并检测治疗前后血压及血浆ET的改变，结果：磁极针组治疗后患者血压及血浆ET含量较治疗前明显下降（P＜0．01，P＜0．01），对照组患者血压较治疗前明显下降（P＜0．05），血浆ET含量治疗前后无显著差异（P＜0．05），结论：磁极针能有效降低高血病患者血压及抑制内皮素的过量释放，提示磁极针对高血压病有积极的治疗价值。     

针刺对阻塞性睡眠呼吸暂停低通气综合征患者血氧饱和度的影响

目的:探讨针刺对阻塞性睡眠呼吸暂停低通气综合征(OSAHS)患者睡眠中血氧饱和度的影响,评价针刺对本病的临床疗效.方法:30例OSAHS患者,针刺上廉泉、风府、哑门、风池等穴位,每周治疗3～5次,治疗30次后观察针刺治疗前后呼吸暂停低通气指数(AHI)、平均血氧饱和度(MSaO2)、最低血氧饱和度(LSaO2)、氧减指数(ODI4)、血氧饱和度＜90%氧减时平均血氧饱和度、最长氧减时间等指标.结果:针刺治疗OSAHS有效率23.3%.针刺后AHI、ODI4明显减少(P＜0.01);LSaO2明显升高(P＜0.01),MSaO2、血氧饱和度＜90%氧减时平均血氧饱和度升高(P＜0.05);最长氧减时间无明显变化(P＞0.05).结论:本针刺方法对OSAHS产生干预作用,可减轻患者的缺氧程度.针刺可成为改善OSAHS患者缺氧状况的治疗方法之一.     

针刺对不同疾病患者血压与脉率的影响

目的 研究针刺对不同类型患者收缩压、舒张压和脉率的影响.方法 对106名受试者在针刺前和起针后立即测量血压和脉率,并咨询有无高血压病史及针刺史,记录下取穴和中西医诊断结果,以便评估针刺不同穴位有不同疾病患者的血压和脉率的作用.结果 针刺后收缩压、舒张压、脉率较针刺前均有不同程度的下降,且差异有统计学意义(P<0.01).针刺史和高血压病史可能不是针刺影响血压、脉率的因素(P>0.05).有些穴位与血压有关;有些穴位与脉率有关(P<0.05或P<0.01).结论 针刺某些穴位对血压和脉率有一定的影响.     

针刺对急性脑梗塞病人血浆神经降压素水平变化的观察

观察针刺治疗急性脑梗塞对病人血浆NT水平变化的影响,探讨针刺治疗急性脑梗塞的作用机理。结果证实,针刺治疗急性脑梗塞,可使病人血浆NT含量加快升高,且针刺组优于对照组（P＜0.05),从而表明针刺具有防止NT水平降低以缩短急性脑梗塞病程的作用。     

早期针刺治疗对高血压脑出血微创术后患者意识状态影响临床观察

[目的]观察针刺治疗对高血压脑出血微创术后患者意识状态的影响。[方法]将研究对象随机分为微创术后常规治疗加针刺组(命名为治疗组,下同)患者20例、微创术后常规治疗组(命名为对照组,下同)患者20例。分别评定两组入院时、入院第4天、第10天、第20天、第30天的格拉斯哥昏迷量表(GCS)积分情况。[结果]治疗组与对照组GCS评分第30天时比较差异有统计学意义(P<0.01),两组间第30天时间相点与第4天时间相点GCS积分差值比较差异有统计学意义(P<0.01)。[结论]早期针刺治疗对高血压脑出血微创术后患者具有较好的促醒作用。     

Effect of Solanum torvum on blood pressure and metabolic alterations in fructose hypertensive rats

Ethnopharmacological relevance

Solanum torvum (Solanaceae) is a plant used in Cameroon ethnomedicine for the treatment of hypertension.

Aim of the study

The present study was aimed to determine the effect of ethanolic extract of Solanum torvum (100 and 300 mg/kg; p.o. for 6 weeks) on systolic blood pressure (SBP), vascular reactivity, serum glucose, triglycerides, cholesterol, insulin and uric acid in fructose-induced hypertension.

Materials and methods

The effect of ethanolic extract of Solanum torvum (100 and 300 mg/kg; p.o. for 6 weeks) on fructose (10%) induced rise in blood pressure was tested by invasive and non-invasive measurements and the biochemical parameters were studied by using standard kits.

Results

Ethanolic extract of Solanum torvum reduced systolic blood pressure, vascular reactivity changes to catecholamines and reversed the metabolic alterations induced by fructose. The cumulative concentration response curve (CCRC) of Angiotensin II (Ang II) using isolated strip of ascending colon was shifted towards right in rats treated with ethanolic extract of Solanum torvum.

Conclusions

In conclusion, ethanolic extract of Solanum torvum could prevent the development of high blood pressure induced by a diet rich in fructose probably by reversing the metabolic alterations induced by fructose.